EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
biological activity | Physostigmine salicylate (ethine salicylate) is a reversible acetylcholinesterase (AChE) inhibitor. Physostigmine salicyl can penetrate the blood-brain barrier and stimulate central cholinergic neurotransmission. Physostigmine salicyl can reverse memory deficits in transgenic mice with Alzheimer's disease. Physostigmine salicylate is also an antidote for anticholinergic intoxication. |
Animal Model:
| Heterozygous transgenic mice (Tg(+) mice) |
Dosage:
| 0.03, 0.1, and 0.3 mg/kg |
Administration:
| SC; daily for 6 weeks |
Result:
| Tended to normalize the contextual memory deficit in Tg(+) animals so that they became more similar to Tg(-) animals. |
Use | is an ophthalmic medication for the treatment of primary angle-closure glaucoma, occasionally primary open-angle glaucoma. |